[Characteristics of subpopulations of lymphocytes and cells of the liver mononuclear phagocyte system in the acute period and in the long term after COVID-19 disease].

Q4 Medicine
S F Krasnenkova, O V Zayratyants, A S Kontorshchikov, K Yu Midiber, V V Pechnikova, L M Mikhaleva
{"title":"[Characteristics of subpopulations of lymphocytes and cells of the liver mononuclear phagocyte system in the acute period and in the long term after COVID-19 disease].","authors":"S F Krasnenkova, O V Zayratyants, A S Kontorshchikov, K Yu Midiber, V V Pechnikova, L M Mikhaleva","doi":"10.17116/patol2026880415","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Comparative analysis of liver subpopulations of lymphocytes and cells of the system of mononuclear phagocytes on the material of autopsies in deaths from acute period of COVID-19, without its previous diseases and bacterial/mycotic superinfection, as well as from noninfection diseases in the distant future after the new coronavirus infection.</p><p><strong>Material and methods: </strong>Study of morphological changes of the liver in 47 deaths from COVID-19, confirmed by a PCR test, and noninfection diseases within 40 to 300 days after a new coronavirus infection. The study did not include those who died with previous liver diseases and comorbid diseases accompanied by liver damage, and in the first two groups of observations - also with bacterial/mycotic superinfection, and after hepatotoxic therapy. 1 group consisted of 10 observations (average age - 75.2 years) with the exudative phase of diffuse alveolar damage (DAD), 2<sup>nd</sup> group - 27 observations (average age - 71.7 years) with the proliferative or exudative-proliferative phases of DAD, 3d group - 10 observations (average age - 84.7 years), died from cardiovascular diseases in the period from 40 to 300 days after the transfer COVID-19. Imunohistochemical (IHC) reactions with antibodies to CD3, CD4, CD8, CD20, CD56 and CD68 were used with statistical analysis.</p><p><strong>Results: </strong>In portal tracts and perisinusoid spaces, the total number of CD3+, CD4+, CD8+, CD56+ and CD20+ lymphocytes and CD68+ cells are not higher in the acute period COVID-19, and in perisinusoid spaces are even less than in observations after a new coronavirus infection in patients died from cardiovascular diseases. The number of intraepithelial CD3+, CD4+, CD8+, CD56+ lymphocytes of the bile ducts of portal tracts was increased, which also infiltrate the walls of small vessels. Number of CD4+ lymphocytes in the stroma and liver parenchyma, ratio CD4+/CD8+ lymphocytes and proliferation of Kupfer cells are most increased in the exudative phase of DAD in COVID-19.</p><p><strong>Conclusion: </strong>The study confirms that the morphological substrate COVID-19-associated liver damage may be ischemic hepatitis and COVID-19-associated cholangiopathy and microangiopathy give it a certain specificity. The revealed changes do not allow to exclude that the pathogenesis of liver damage can be also associated, including with other factors the direct action of SARS-CoV2 or immune disorders associated with COVID-19.</p>","PeriodicalId":8548,"journal":{"name":"Arkhiv patologii","volume":"88 4","pages":"5-13"},"PeriodicalIF":0.0000,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Arkhiv patologii","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.17116/patol2026880415","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: Comparative analysis of liver subpopulations of lymphocytes and cells of the system of mononuclear phagocytes on the material of autopsies in deaths from acute period of COVID-19, without its previous diseases and bacterial/mycotic superinfection, as well as from noninfection diseases in the distant future after the new coronavirus infection.

Material and methods: Study of morphological changes of the liver in 47 deaths from COVID-19, confirmed by a PCR test, and noninfection diseases within 40 to 300 days after a new coronavirus infection. The study did not include those who died with previous liver diseases and comorbid diseases accompanied by liver damage, and in the first two groups of observations - also with bacterial/mycotic superinfection, and after hepatotoxic therapy. 1 group consisted of 10 observations (average age - 75.2 years) with the exudative phase of diffuse alveolar damage (DAD), 2nd group - 27 observations (average age - 71.7 years) with the proliferative or exudative-proliferative phases of DAD, 3d group - 10 observations (average age - 84.7 years), died from cardiovascular diseases in the period from 40 to 300 days after the transfer COVID-19. Imunohistochemical (IHC) reactions with antibodies to CD3, CD4, CD8, CD20, CD56 and CD68 were used with statistical analysis.

Results: In portal tracts and perisinusoid spaces, the total number of CD3+, CD4+, CD8+, CD56+ and CD20+ lymphocytes and CD68+ cells are not higher in the acute period COVID-19, and in perisinusoid spaces are even less than in observations after a new coronavirus infection in patients died from cardiovascular diseases. The number of intraepithelial CD3+, CD4+, CD8+, CD56+ lymphocytes of the bile ducts of portal tracts was increased, which also infiltrate the walls of small vessels. Number of CD4+ lymphocytes in the stroma and liver parenchyma, ratio CD4+/CD8+ lymphocytes and proliferation of Kupfer cells are most increased in the exudative phase of DAD in COVID-19.

Conclusion: The study confirms that the morphological substrate COVID-19-associated liver damage may be ischemic hepatitis and COVID-19-associated cholangiopathy and microangiopathy give it a certain specificity. The revealed changes do not allow to exclude that the pathogenesis of liver damage can be also associated, including with other factors the direct action of SARS-CoV2 or immune disorders associated with COVID-19.

[COVID-19急性期和长期肝单核吞噬细胞系统淋巴细胞亚群特征]。
目的:比较分析新型冠状病毒感染后急性期无既往疾病和无细菌/真菌重复感染死亡患者和远期无感染死亡患者尸检材料中肝脏淋巴细胞亚群和单核吞噬细胞系统细胞亚群的变化。材料与方法:对47例经PCR检测证实的COVID-19死亡病例和新冠病毒感染后40 ~ 300天内非感染性疾病的肝脏形态学变化进行研究。该研究不包括那些死于既往肝脏疾病和伴随肝损伤的共病疾病的患者,以及前两组观察患者——也包括细菌/真菌双重感染和肝毒性治疗后的患者。1组10例(平均年龄75.2岁)为弥漫性肺泡损伤(DAD)渗出期,2组27例(平均年龄71.7岁)为弥漫性肺泡损伤增殖期或渗出-增殖期,3d组10例(平均年龄84.7岁)为转移后40 ~ 300 d内死于心血管疾病。采用CD3、CD4、CD8、CD20、CD56、CD68抗体免疫组化(IHC)反应进行统计学分析。结果:COVID-19急性期门静脉束和样膜间隙CD3+、CD4+、CD8+、CD56+、CD20+淋巴细胞和CD68+细胞总数均不高于急性期门静脉束和样膜间隙CD3+、CD4+、CD8+、CD8+、CD20+淋巴细胞和CD68+细胞总数,样膜间隙CD3+、CD4+、CD8+淋巴细胞总数甚至低于心血管疾病死亡患者感染新型冠状病毒后观察到的总数。门静脉管壁胆管上皮内CD3+、CD4+、CD8+、CD56+淋巴细胞增多,并向小血管壁浸润。间质和肝实质CD4+淋巴细胞数量、CD4+/CD8+淋巴细胞比例及Kupfer细胞增殖在新冠肺炎患者的渗出期增加最多。结论:本研究证实新型冠状病毒相关肝损伤的形态学底物可能是缺血性肝炎,新型冠状病毒相关胆管病和微血管病使其具有一定的特异性。揭示的变化不能排除肝损伤的发病机制也可能相关,包括与其他因素直接作用的SARS-CoV2或与COVID-19相关的免疫疾病。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Arkhiv patologii
Arkhiv patologii Medicine-Pathology and Forensic Medicine
CiteScore
0.90
自引率
0.00%
发文量
55
期刊介绍: The journal deals with original investigations on pressing problems of general pathology and pathologic anatomy, newest research methods, major issues of the theory and practice as well as problems of experimental, comparative and geographic pathology. To inform readers latest achievements of Russian and foreign medicine the journal regularly publishes editorial and survey articles, reviews of the most interesting Russian and foreign books on pathologic anatomy, new data on modern methods of investigation (histochemistry, electron microscopy, autoradiography, etc.), about problems of teaching, articles on the history of pathological anatomy development both in Russia and abroad.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书